Trial Profile
Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 15 Jul 2019 Status changed from recruiting to completed.
- 04 Jul 2017 New trial record